102 results
8-K
EX-99.1
INVA
Innoviva Inc
9 Nov 22
Innoviva Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress
4:17pm
of the Infectious Disease Society of America which took place from October 19 to October 23, 2022 in Washington, D.C., our wholly owned subsidiary
SC TO-T
EX-99
cxn7a452iwzh1azn2i1z
25 Jul 22
Third party tender offer statement
8:34am
SC TO-C
EX-2.1
9oa3k8p
11 Jul 22
Information about tender offer
3:46pm
8-K
EX-2.1
jrbnobp6g3990un
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am
425
j4m dpjh0qof1erwxc
11 Jul 22
Business combination disclosure
7:38am
SC TO-T
EX-99
7d5apftw60b 8ed0ewix
7 Jun 22
Third party tender offer statement
9:04am
SC TO-C
EX-2.1
19anq
23 May 22
Information about tender offer
8:53pm
8-K
EX-2.1
csx7csc
23 May 22
Tender and Support Agreement
8:51pm
8-K
EX-99.2
lm38wv
28 Sep 15
Regulation FD Disclosure
12:00am
8-K
fboherpwv
28 Sep 15
Regulation FD Disclosure
12:00am
8-K
EX-99.1
4h9u s6byye9v2rwr
28 Sep 15
Regulation FD Disclosure
12:00am